CheckImmune is a spin-off company of Charité Universitätsmedizin Berlin with strong links to academic state-of-the art research. CheckImmune is providing biomarker studies with focus on novel immunotherapeutics (small molecules, biologics, Advanced Therapy Medicinal Products – ATMPs) and immunological challenges in other medical areas. CheckImmune is accredited according to ISO 17025 and 15189 and fulfills the requirements of GCLP (Good Clinical Laboratory Practice).
We are a team of well recognized experts for biomarker analyses and data interpretation.
With a track record of more than 60 industry-sponsored trials and 60,000 samples we have earned an excellent international reputation.